Really? http://www.biopharma-reporter.com/Markets-Regulations/Dr-Reddy-s-looks-to-bring-biosimilars-to-EU-within-five-years http://www.biopharma-reporter.com/M

Really? http://www.biopharma-reporter.com/Markets-Regulations/Dr-Reddy-s-looks-to-bring-biosimilars-to-EU-within-five-years http://www.biopharma-reporter.com/Markets-Regulations/Dr-Red... Because at $75M to $250M a pop, they're way cheaper than developing a new Biologic ($1B-$2B) and that's because while none have been approved yet, the pathway in the Patient Protection and Affordable Care Act is shorter than that for a new Biologic. I think Big Pharma will do what it takes to make this happen myself. Just like Google will apparently do just about anything for the bottom line despite their corporate motto.